do-me/EUR-LEX huggingface dataset:
Case T-210/18: Action brought on 22 March 2018 — Porsche v EUIPO — Autec (Cars)
Date: 2018-03-22
Institutions: General Court
Subjects: designs and models, motor car, motor vehicle








C_2018166EN.01004602.xml










14.5.2018   


EN


Official Journal of the European Union


C 166/46





Action brought on 22 March 2018 — Porsche v EUIPO — Autec (Cars)
(Case T-210/18)
(2018/C 166/59)
Language in which the application was lodged: German

Parties


Applicant: Dr. Ing. h.c. F. Porsche AG (Stuttgart, Germany) (represented by: C. Klawitter, lawyer)

Defendant: European Union Intellectual Property Office (EUIPO)

Other party to the proceedings before the Board of Appeal: Autec AG (Nuremberg, Germany)

Details of the proceedings before EUIPO


Proprietor of the design at issue: Applicant

Design at issue: Community design No 198387-0001

Contested decision: Decision of the Third Board of Appeal of EUIPO of 19 January 2018 in Case R 941/2016-3

Form of order sought

The applicant claims that the Court should:






—


annul the contested decision and dismiss the application for a declaration of invalidity in respect of the contested Community design No 198387-0001.





Pleas in law







—


Infringement of Article 5 of Regulation No 6/2002;










—


Infringement of Article 6 of Regulation No 6/2002.
Case T-766/16 R: Order of the President of the General Court of 22 March 2018 — Hércules Club de Fútbol v Commission (Interim proceedings — State aid — Aid granted by Spain in favour of certain professional football clubs — Public guarantee granted by a public body — Decision declaring the aid incompatible with the internal market — Application for a stay of proceedings — Lack of urgency)
Date: 2018-03-22
Institutions: General Court
Subjects: EU competition policy, Spain, State aid, capital increase, control of State aid, loan, professional sport, sports body








C_2018182EN.01002201.xml










28.5.2018   


EN


Official Journal of the European Union


C 182/22





Order of the President of the General Court of 22 March 2018 — Hércules Club de Fútbol v Commission
(Case T-766/16 R)
((Interim proceedings - State aid - Aid granted by Spain in favour of certain professional football clubs - Public guarantee granted by a public body - Decision declaring the aid incompatible with the internal market - Application for a stay of proceedings - Lack of urgency))
(2018/C 182/25)
Language of the case: Spanish

Parties


Applicant: Hércules Club de Fútbol, SAD (Alicante, Spain) (represented by: S. Rating and Y. Martínez Mata, lawyers)

Defendant: European Commission (represented by: G. Luengo, B. Stromsky and P. Němečková, acting as Agents)

Intervener in support of the form of order sought by the applicant: Kingdom of Spain (represented by: A. Gavela Llopis, acting as Agent)

Re:

Application on the basis of Articles 278 TFEU and 279 TFEU seeking a stay of execution of Commission Decision (EU) 2017/365 of 4 July 2016 on the State aid SA.36387 (2013/C) (ex 2013/NN) (ex 2013/CP) granted by Spain to Valencia Club de Fútbol, Hércules Club de Fútbol, SAD and Elche Club de Fútbol, SAD (OJ 2017 L 55, p. 12).

Operative part of the order







1.


The application for interim measures is rejected.










2.


The order of 11 November 2016, Hércules Club de Fútbol v Commission (T-766/16 R), is set aside.










3.


The costs are reserved.
Case T-80/16: Judgment of the General Court of 22 March 2018 — Shire Pharmaceuticals Ireland v EMA (Medicinal products for human use — Validation of an application for designation as an orphan medicinal product — Significant benefit — EMA decision refusing to validate an application for designation as an orphan medicinal product — Article 3(1)(b) and Article 5(1), (2) and (4) of Regulation (EC) No 141/2000)
Date: 2018-03-22
Institutions: General Court
Subjects: disease prevention, drugs classification, market approval, medicinal product








C_2018166EN.01002701.xml










14.5.2018   


EN


Official Journal of the European Union


C 166/27





Judgment of the General Court of 22 March 2018 — Shire Pharmaceuticals Ireland v EMA
(Case T-80/16) (1)

((Medicinal products for human use - Validation of an application for designation as an orphan medicinal product - Significant benefit - EMA decision refusing to validate an application for designation as an orphan medicinal product - Article 3(1)(b) and Article 5(1), (2) and (4) of Regulation (EC) No 141/2000))
(2018/C 166/34)
Language of the case: English

Parties


Applicant: Shire Pharmaceuticals Ireland Ltd (Dublin, Ireland) (represented by: D. Anderson QC, M. Birdling, barrister, G. Castle and S. Cowlishaw, solicitors)

Defendant: European Medicines Agency (EMA) (represented by: T. Jabłoński, N. Rampal Olmedo and M. Tovar Gomis, acting as Agents)

Intervener in support of the defendant: European Commission (represented by: K. Petersen and A. Sipos, acting as Agents)

Re:

Application pursuant to Article 263 TFEU seeking the annulment of the EMA decision of 15 December 2015 refusing to validate the application submitted by Shire Pharmaceuticals Ireland for designation of Idursulfase-IT as an orphan medicinal product.

Operative part of the judgment

The Court:






1.


Annuls the decision of the European Medicines Agency (EMA) dated 15 December 2015 refusing to validate the application submitted by Shire Pharmaceuticals Ireland Ltd seeking the designation of Idursulfase-IT as an orphan medicinal product;










2.


Orders the EMA to bear its own costs, as well as those of Shire Pharmaceuticals Ireland;










3.


Orders the European Commission to bear its own costs.






(1)  OJ C 136, 18.4.2016.
Non-opposition to a notified concentration (Case M.8728 — Diamond Transmission Corporation/InfraRed Capital Partners/JV) (Text with EEA relevance. )
Date: 2018-03-22
Institutions: European Commission
Subjects: economic concentration, electrical energy, energy transport, holding company, investment company, merger control








C_2018107EN.01000201.xml










22.3.2018   


EN


Official Journal of the European Union


C 107/2





Non-opposition to a notified concentration
(Case M.8728 — Diamond Transmission Corporation/InfraRed Capital Partners/JV)
(Text with EEA relevance)
(2018/C 107/02)
On 15 March 2018, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:






—


in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,










—


in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32018M8728. EUR-Lex is the online access to European law.






(1)  OJ L 24, 29.1.2004, p. 1.